First gene therapy costs $850,000 | January 8, 2018 Issue - Vol. 96 Issue 2 | Chemical & Engineering News
Volume 96 Issue 2 | p. 10 | Concentrates
Issue Date: January 8, 2018

First gene therapy costs $850,000

By Ryan Cross
Department: Business
Keywords: Gene therapy, Luxturna, Spark Therapeutics, drug costs, blindness

The first gene therapy to treat genetic disease approved by the U.S. Food & Drug Administration will cost $850,000. Luxturna, from Spark Therapeutics, is designed to partially restore vision in people with a rare form of inherited blindness. The one-time treatment was expected to cost $1 million or more. Spark will offer rebates to insurance companies if patients do not improve in short- or long-term tests of light sensitivity. Spark is also in talks with the Centers for Medicare & Medicaid Services about letting government or commercial drug payers foot the bill in installments.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment